Literature DB >> 16823583

Correlation of drug utilisation and morbidity at the municipality level. High use of antibiotics associated with low use of antihypertensives.

J Lars G Nilsson1, Gunnar Lindberg, Hans Johansson, Arne Melander.   

Abstract

OBJECTIVE: The aim of the study was to explore the relationship between Swedish drug sales data per municipality and morbidity per municipality. The morbidity was expressed as "sickness numbers" which are assumed to function as proxy for morbidity.
METHODS: Sickness numbers per municipality were correlated to volumes of drug sales per municipality in 2003. In addition, the sales volumes of antibiotics were correlated to the sales volumes of other drugs.
RESULTS: We found significant positive correlations between municipality sickness numbers and sales volumes for most drug groups, except for antibiotics where the correlations were negative in all age groups. When the volumes of antibiotics were related to the volumes of other drug groups it was observed that municipalities with volumes of antibiotics above the national average had reduced volumes of cardiovascular drugs, especially of diuretics, beta blockers and calcium antagonists, all primarily used as antihypertensives. For ACE inhibitors and statins, no such relationship was found.
CONCLUSION: The findings might suggest a link between infection and hypertension, but a cause-effect relation is not established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823583     DOI: 10.1007/s00228-006-0157-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Antibiotics in primary prevention of myocardial infarction among elderly patients with hypertension.

Authors:  Paul Brassard; Chantal Bourgault; James Brophy; Abbas Kezouh; Bruno Rainville; Marianne Xhignesse; Samy Suissa
Journal:  Am Heart J       Date:  2003-05       Impact factor: 4.749

2.  The role of drug use data in public health research.

Authors:  F E Vegni; P Wilkinson
Journal:  Ann Ig       Date:  2004 May-Jun

Review 3.  Chronic infections and coronary heart disease: is there a link?

Authors:  J Danesh; R Collins; R Peto
Journal:  Lancet       Date:  1997-08-09       Impact factor: 79.321

4.  Antibiotics in the prevention of heart attacks.

Authors:  John Danesh
Journal:  Lancet       Date:  2005 Jan 29-Feb 4       Impact factor: 79.321

5.  Association between periodontal disease and left ventricle mass in essential hypertension.

Authors:  Fabio Angeli; Paolo Verdecchia; Concetta Pellegrino; Rosaria Giulia Pellegrino; Giacinto Pellegrino; Lucio Prosciutti; Claudia Giannoni; Stefano Cianetti; Maurizio Bentivoglio
Journal:  Hypertension       Date:  2003-02-10       Impact factor: 10.190

Review 6.  Deprivation indices: their interpretation and use in relation to health.

Authors:  V Carstairs
Journal:  J Epidemiol Community Health       Date:  1995-12       Impact factor: 3.710

7.  Antibiotics for the secondary prevention of ischemic heart disease: a meta-analysis of randomized controlled trials.

Authors:  Brian J Wells; Arch G Mainous; Lori M Dickerson
Journal:  Arch Intern Med       Date:  2004-10-25

8.  Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.

Authors:  Christopher M O'Connor; Michael W Dunne; Marc A Pfeffer; Joseph B Muhlestein; Louis Yao; Sandeep Gupta; Rebecca J Benner; Marian R Fisher; Thomas D Cook
Journal:  JAMA       Date:  2003-09-17       Impact factor: 56.272

9.  Methodological issues in using drugs data in epidemiology.

Authors:  F E Vegni; P Wilkinson
Journal:  Ann Ig       Date:  2004 May-Jun

10.  Antibiotics in primary prevention of stroke in the elderly.

Authors:  Paul Brassard; Chantal Bourgault; James Brophy; Abbas Kezouh; Samy Suissa
Journal:  Stroke       Date:  2003-08-07       Impact factor: 7.914

View more
  1 in total

1.  Aggregated and individual pharmacy record data. Association between antibiotic and antihypertensive drug use.

Authors:  J Lars G Nilsson; Gunnar Lindberg; Gunilla Ringbäck Weitoft; Arne Melander
Journal:  Eur J Clin Pharmacol       Date:  2008-10-11       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.